Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects

ClinicalTrials.gov ID: NCT05902962

Public ClinicalTrials.gov record NCT05902962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy

Study identification

NCT ID
NCT05902962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
PYC Therapeutics
Industry
Enrollment
17 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 20, 2023 (Actual)
Primary completion
Aug 8, 2025 (Actual)
Completion
Aug 8, 2025 (Actual)
Last update posted
May 29, 2026

2023 – 2025

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
University of Florida Health Jacksonville Florida 32209 —
Bascom Palmer Eye Institute University of Miami Miami Florida 33136 —
University of Michigan Kellogg Eye Center Ann Arbor Michigan 48105 —
Oregon Health and Science University - Casey Eye Institute Portland Oregon 97239 —
Retina Foundation of the Southwest Dallas Texas 75321 —
Baylor College of Medicine- Alkek Eye Center Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05902962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05902962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →